Processing of bacterial antigens for peptide presentation on MHC class I molecules

Immunological Reviews

Volumn 172, Issue , 1999, Pages 153-162

  Wick, Mary Jo ^a   Ljunggren, Hans Gustaf ^b  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL VACUOLE; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0033452344     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01363.x     Document Type: Article

References (94)

1. 1. Yewdell JW, Bennink JR. Cell biology of antigen processing and presentation to MHC class I molecule-restricted T lymphocytes. Adv Immunol 1992;52:1-123.
2. 2. Cresswell P. Assembly, transport and function of MHC class II molecules. Annu Rev Immunol 1994;12:259-293.
3. 3. Heemels M-T, Ploegh HL. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem 1995;64:463-491.
4. 4. Wolf PR, Ploegh HL. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu Rev Cell Dev Biol 1995;11:267-306.
5. 5. Lechler R, Aichinger G, Lightstone L. The endogenous pathway of MHC class II presentation. Immunol Rev 1996;151:51-79.
6. 6. Rock KL. A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today 1996;17:131-137.
7. 7. Jondal M, Schirmbeck R, Reimann J. MHC class I-restricted CTL responses to exogenous antigens. Immunity 1996;5:295-302.
8. 8. Reimann J, Kaufmann SHE. Alternative antigen processing pathways in anti-infective immunity. Curr Opin Immunol 1997;9:462-469.
9. 9. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 1997;15:821-850.
10. + T cell responses to infectious agents, tumors, transplants and vaccines. Adv Immunol 1999;73:1-77.
11. + T cells requires secretion of hemolysin and intracellular bacterial growth. J Immunol 1990;145:3540-3546.
12. 12. Hiltbolt EM, Safley SA, Ziegler HK. The presentation of class I and class II epitopes of listeriolysin O is regulated by intracellular localization and by intercellular spread of Listeria monocytogenes. J Immunol 1996;157:1163-1175.
13. 13. Bevan MJ. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 1976;143:1283-1288.
14. 14. Guermonprez P, Ladant D, Karimova G, Ullmann A, Leclerc C. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway. J Immunol 1999;162:1910-1016.
15. 15. Rüssmann H, Shams H, Poblete F, Fu Y, Galán JE, Donis RO. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 1998;281:565-568.
16. 16. Falgarone G, Blanchard HS, Virecoulon F, Simonet M, Breban M. Coordinate involvement of invasin and Yop proteins in a Yersinia pseudotuberculosis-specific class I-restricted cytotoxic T cell-mediated response. J Immunol 1999;162:2875-2883.
17. 17. Kovacsovics-Bankowski M, Rock KL. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995;267:243-246.
18. 18. Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 1995;3:783-791.
19. 19. Huang AYC, Bruce AT, Pardoll DM, Levitsky HI. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 1996;4:349-355.
20. 20. Norbury CC, Chambers BJ, Prescott AR, Ljunggren H-G, Watts C. Constitutive macropinocytosis allows TAP-dependent major hisrocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol 1997;27:280-288.
21. 21. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993;361:359-362.
22. 22. Wick MJ, Pfeifer JD, Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation. Eur J Immunol 1996;26:2790-2799.
23. 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J Immunol 1996;156:4182-4190.
24. 24. Schirmbeck R, Melber K, Reimann J. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur J Immunol 1995;25:1063-1070.
25. 25. Bachmann MF, et al. TAP1-independent loading of class I molecules by exogenous viral proteins. Eur J Immunol 1995;25:1739-1743.
26. 26. Liu T, Chambers B. Diehl AD, Van Kaer L, Jondal M, Ljunggren H-G. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells. J Immunol 1997;159:5364-5371.
27. 27. Austyn JM. New insights into the mobilization and phagocytic activity of dendritic cells. J Exp Med 1996;183:1287-1292.
28. 28. Hart DNJ. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997;90:3245-3287.
29. 29. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
30. 30. Steinman RM. Dendritic cells. In: Paul WE, ed. Fundamental immunology. 4th ed. Philadelphia: Lippincott-Raven; 1999. p. 547-573.
31. 31. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α J Exp Med 1994;179:1109-1118.
32. 32. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
33. 33. Nijman HW, et al. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J Exp Med 1995;182:163-174.
34. 34. Winzler C, et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 1997;185:317-328.
35. 35. Mitchell DA, Nair SK, Gilboa E. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells. Eur J Immunol 1998;28:1923-1933.
36. 36. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997;158:2723-2730.
37. 37. Reis e Sousa C, Stahl PD, Austyn JM. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 1993;178:509-519.
38. 38. Inaba K, Inaba M, Naito M, Steinman RM. Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guérin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 1993;178:479-488.
39. 39. Scheicher C, Mehlig M, Dienes H-P, Reske K. Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 α and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur J Immunol 1995;25:1566-1572.
40. + cytotoxic T lymphocytes. Eur J Immunol 1996;26:2595-2600.
41. 41. Inaba K et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998;188:2163-2173.
42. 42. Esposito-Farese M-E, et al. Membrane and soluble FcγRII/III modulate the antigen-presenting capacity of murine dendritic epidermal Langerhans cells for IgG-complexed antigens. J Immunol 1995;154:1725-1736.
43. 43. Engering AJ, et al. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur J Immunol 1997;27:2417-2425.
44. 44. Tan MCAA, et al. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol 1997;27:2426-2435.
45. 45. Steinman RM, Swanson J. The endocytic activity of dendritic cells. J Exp Med 1995;182:283-288.
46. 46. Lutz MB, et al. Intracellular routes and selective retention of antigens in midly acidic cathepsin D/lysosome-associated membrane protein-1/MHC class II-positive vesicles in immature dendritic cells. J Immunol 1997;159:3707-3716.
47. 47. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997;388:782-786.
48. 48. Pierre P, et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997;388:787-792.
49. 49. Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998;93:1135-1145.
50. 50. De Smedt T, et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 1996;184:1413-1424.
51. + T cells. J Immunol 1995;154:5071-5079.
52. 52. Kang K, Kubin M, Cooper KD, Lessin SR, Trinchieri G, Rook AH. IL-12 synthesis by human Langerhans cells. J Immunol 1996;156:1402-1407.
53. 53. Reis e Sousa C, et al. In vivo microbial stimulation induces rapid CD40 ligand-independent producton of interleukin-12 by dendritic cells and their redistribution to T cell areas. J Exp Med 1997;186:1819-1829.
54. 54. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.
55. 55. Unanue ER. Macrophages, antigen-presenting cells, and the phenomena of antigen handling and presentation. In: Paul WE, ed. Fundamental immunology. 3rd ed. New York: Raven Press, Ltd; 1993. p. 111-144.
56. 56. Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997;99:2818-2825.
57. 57. Skeen MJ, Miller MA, Shinnick TM, Ziegler HK. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J Immunol 1996;156:1196-1206.
58. 58. Crowley M, Inaba K, Steinman RM. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J Exp Med 1990;172:383-386.
59. 59. Matsuno K, Ezaki T, Kudu S, Uehara Y. A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J Exp Med 1996;183:1865-1878.
60. + T cells. J Exp Med 1997;185:2133-2141.
61. 61. Brossart P, Goldrath AW, Butz EA, Martin S, Bevan MJ. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J Immonol 1997;158:3270-3276.
62. 62. Salomon B, Cohen JL, Masurier C, Klatzmann D. Three populations of mouse lymph node dendritic cells with different origins and dynamics. J Immunol 1998;160:708-717.
63. 63. Jones BD, Ghori N, Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J Exp Med 1994;180:15-23.
64. 64. Richter-Dahlfors A, Buchan AMJ, Finlay BB. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect in phagocytes in vivo. J Exp Med 1997;186:569-580.
65. 65. Fields PI, Swanson RV, Haidaris CG, Heffron F. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sci USA 1986;83:5189-5193.
66. 66. Oh Y-K, Alpuche-Aranda C, Berthiaume E, Jinks T, Miller SI, Swanson JA. Rapid and complete fusion of macrophage lysosomes with phagosomes containing Salmonella typhimurium. Infect Immun 1996;64:3877-3883.
67. 67. Foster JW, Spector MP. How Salmonella survive against the odds. Annu Rev Microbiol 1995;49:145-174.
68. 68. Lindgren SW, Heffron F. To sting or be stung: bacteria-induced apoptosis. Trends Microbiol 1997;5:263-264.
69. 69. Slauch J, Taylor R, Maloy S. Survival in a cruel world: how Vibrio cholerae and Salmonella respond to an unwilling host. Genes Dev 1997;11:1761-1774.
70. 70. Chen LM, Kaniga K, Galán JE. Salmonella spp. are cytotoxic for cultured macrophages. Mol Microbiol 1996;21:1101-1115.
71. 71. Wick MJ, Harding CV, Twesten NJ, Normark SJ, Pfeifer JD. The phoP locus influences processing and presentation of Salmonella typhimurium antigens by activated macrophages. Mol Microbiol 1995;16:465-476.
72. + cytotoxic T cells. J Exp Med 1990;172:1083-1090.
73. 73. Flynn JL, Weiss WR, Norris KA, Seifert HS, Kumar S, So M. Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system. Mol Microbiol 1990;4:2111-2118.
74. 74. Sztein MB, Tanner MK, Polotsky Y, Orenstein JM, Levine MM. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J Immunol 1995;155:3987-3993.
75. 75. Turner SJ, Carbone FR, Strugnell RA. Salmonella typhimurium ΔaroA ΔaroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice. Infect Immun 1993;61:5374-5380.
76. + cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J Immunol 1999;162:372-379.
77. 77. Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 1996;156:1490-1496.
78. 78. Gao, X-M, Tite JP, Lipscombe M, Rowland-Jones S, Ferguson DJP, McMichael AJ. Recombinant Salmonella typhimurium strains that invade nonphagocytic cells are resistant to recognition by antigen-specific cytotoxic T lymphocytes. Infect Immun 1992;60:3780-3789.
79. 79. Harding CV, Pfeifer JD. Antigen expressed by Salmonella typhimurium is processed for class I major histocompatibility complex presentation by macrophages but not infected epithelial cells. Immunology 1994;83:670-674.
80. 80. Svensson M, Stockinger B, Wick MJ. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J Immunol 1997;158:4229-4236.
81. 81. Filgueira L, Nestlé FO, Rittig M, Joller HI, Groscurth P. Human dendritic cells phagocytose and process Borrelia burgdorferi. J Immunol 1996;157:2998-3005.
82. 82. Will A, Blank C, Rollinghoff M, Moll H. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis. Eur J Immunol 1992;22:1341-1347.
83. 83. Rescigno M, et al. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci USA 1998;95:5229-5234.
84. 84. Svensson M, Wick MJ. Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells. Eur J Immunol 1999;29:180-188.
85. 85. Henderson RA, Watkins SC, Flynn JL. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 1997;159:635-643.
86. 86. Ojcius DM, et al. Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-spedfic T cells. J Immunol 1998;160:1297-1303.
87. + dendritic cells initiating cytokine expression. Eur J Immunol 1999;29:1107-1115.
88. 88. Bellone M, et al. Processing of engulfed apoptotic bodies yields T cell epitopes. J Immunol 1997;159:5391-5399.
89. 89. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-89.
90. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998;188:1359-1368.
91. 91. Rovere P, et al. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 1998;161:4467-4471.
92. 92. Monack DM, Mecsas J, Bouley D, Falkow S. Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J Exp Med 1998;188:2127-2137.
93. 93. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR. Immunosuppressive effects of apoptotic cells. Nature 1997;390:350-351.
94. 94. Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998;188:387-392.